Sexual and reproductive health rights in Africa.

1 Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55: 694–700. 2 National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care, clinical guideline 23. December, 2004: http://www.nice.org.uk/page.aspx?o=cg023 (accessed May 28, 2006). 3 Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004; 61: 1097–103. 4 Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006; 163: 101–08. 5 Bambauer KZ, Adams AS, Zhang F, et al. Physician alerts to increase antidepressant adherence: fax or fi ction? Arch Intern Med 2006; 166: 498–504. 6 Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol 1994; 8: 48–53. 7 Paykel ES, Hart D, Priest RG. Changes in public attitudes to depression during the Defeat Depression Campaign. Br J Psychiatry 1998; 173: 519–22. 8 Althaus D, Stefanek J, Hasford J, Hegerl U. Knowledge and attitude of the general public regarding symptoms, etiology, and possible treatments of depressive illnesses. Nervenarzt 2002; 73: 659–64. 9 Pyne JM, Rost KM, Farahati F, et al. One size fi ts some: the impact of patient treatment attitudes on the cost-eff ectiveness of a depression primary-care intervention. Psychol Med 2005; 35: 839–54. 10 Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 2001; 52: 1615–20. 11 Aikens JE, Kroenke K, Swindle RW, Eckert GJ. Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen Hosp Psychiatry 2005; 27: 229–36. 12 Beck CA, Patten SB. Adjustment to antidepressant utilization rates to account for depression in remission. Compr Psychiatry 2004; 45: 268–74. 13 Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841–45. 14 Bultman DC, Svarstad BL. Eff ects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns 2000; 40: 173–85. 15 Ashton AK, Jamerson BD, Weinstein WL, Wagoner C. Antidepressantrelated adverse eff ects impacting treatment compliance: results of a patient survey. Curr Ther Res Clin Exp 2005; 66: 96–106. 16 Sleath B, Rubin RH, Huston SA. Hispanic ethnicity, physician-patient communication, and antidepressant adherence. Compr Psychiatry 2003; 44: 198–204. 17 Brambilla P, Cipriani A, Hotopf M, Barbui C. Side-eff ect profi le of fl uoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry 2005; 38: 69–77. 18 Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: infl uence of patient-physician communication. JAMA 2002; 288: 1403–09. 19 Bull SA, Hunkeler EM, Lee JY, et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother 2002; 36: 578–84. 20 Aikens JE, Nease DE Jr, Nau DP, Klinkman MS, Schwenk TL. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 2005; 3: 23–30.